Skip to content

Reverse-Loop Upper Arm Arteriovenous Graft

Reverse-Loop Upper Arm Arteriovenous Graft for Chronic Hemodialysis

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00708825
Enrollment
7
Registered
2008-07-02
Start date
2008-01-31
Completion date
2008-12-31
Last updated
2008-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Vessel Prosthesis

Brief summary

Background: A conventional configured prosthetic arteriovenous graft (AVG) usually wastes most upper arm vessels that a reverse-loop design may conserve. This study examined the feasibility of the AVG construction and its outcome. Methods: Retrospective review of clinical outcomes of reverse-loop upper arm AVG patients. Measures included hemodialysis function, duplex scan, procedural complications, and follow-up interventions

Interventions

None listed

Sponsors

Min-Sheng General Hospital
CollaboratorOTHER
Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* compromized forearm and elbow options

Exclusion criteria

* unstable

Design outcomes

Primary

MeasureTime frame
functional event-free primary patencyevent-free time

Secondary

MeasureTime frame
Measures included hemodialysis function, duplex scan, procedural complications, and follow-up interventions.events (month)

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026